nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Cytochrome P450 3A4 Inhibitors—Colchicine—primary biliary cirrhosis	0.81	1	CiPCiCtD
Aprepitant—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0306	0.421	CbGbCtD
Aprepitant—CYP2C9—Colchicine—primary biliary cirrhosis	0.0266	0.366	CbGbCtD
Aprepitant—CYP3A4—Colchicine—primary biliary cirrhosis	0.0155	0.213	CbGbCtD
Aprepitant—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.0111	CcSEcCtD
Aprepitant—Heartburn—Ursodeoxycholic acid—primary biliary cirrhosis	0.001	0.0107	CcSEcCtD
Aprepitant—Heartburn—Chenodeoxycholic acid—primary biliary cirrhosis	0.001	0.0107	CcSEcCtD
Aprepitant—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.000902	0.0379	CbGpPWpGaD
Aprepitant—Cardiovascular disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000783	0.00841	CcSEcCtD
Aprepitant—Cardiovascular disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000783	0.00841	CcSEcCtD
Aprepitant—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00802	CcSEcCtD
Aprepitant—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00802	CcSEcCtD
Aprepitant—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000728	0.00782	CcSEcCtD
Aprepitant—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000728	0.00782	CcSEcCtD
Aprepitant—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00748	CcSEcCtD
Aprepitant—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00748	CcSEcCtD
Aprepitant—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.000684	0.0287	CbGpPWpGaD
Aprepitant—Eructation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000676	0.00726	CcSEcCtD
Aprepitant—Eructation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000676	0.00726	CcSEcCtD
Aprepitant—TACR1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.000669	0.0281	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000645	0.0271	CbGpPWpGaD
Aprepitant—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.000622	0.00668	CcSEcCtD
Aprepitant—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.000622	0.00668	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000585	0.0246	CbGpPWpGaD
Aprepitant—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00617	CcSEcCtD
Aprepitant—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00617	CcSEcCtD
Aprepitant—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000569	0.00611	CcSEcCtD
Aprepitant—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000569	0.00611	CcSEcCtD
Aprepitant—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000525	0.00564	CcSEcCtD
Aprepitant—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000525	0.00564	CcSEcCtD
Aprepitant—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.000521	0.0056	CcSEcCtD
Aprepitant—CYP3A5—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000518	0.0218	CbGpPWpGaD
Aprepitant—Dehydration—Colchicine—primary biliary cirrhosis	0.000517	0.00556	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000501	0.00538	CcSEcCtD
Aprepitant—Cramp muscle—Colchicine—primary biliary cirrhosis	0.000501	0.00538	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00049	0.00527	CcSEcCtD
Aprepitant—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00049	0.00527	CcSEcCtD
Aprepitant—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000468	0.00503	CcSEcCtD
Aprepitant—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000468	0.00503	CcSEcCtD
Aprepitant—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000465	0.00499	CcSEcCtD
Aprepitant—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000465	0.00499	CcSEcCtD
Aprepitant—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.000461	0.00495	CcSEcCtD
Aprepitant—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000456	0.0049	CcSEcCtD
Aprepitant—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000456	0.0049	CcSEcCtD
Aprepitant—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000451	0.00485	CcSEcCtD
Aprepitant—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000451	0.00485	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00483	CcSEcCtD
Aprepitant—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00483	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00483	CcSEcCtD
Aprepitant—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00483	CcSEcCtD
Aprepitant—Neutropenia—Colchicine—primary biliary cirrhosis	0.000449	0.00483	CcSEcCtD
Aprepitant—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00475	CcSEcCtD
Aprepitant—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00475	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00473	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00473	CcSEcCtD
Aprepitant—CYP3A5—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000441	0.0185	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000432	0.0182	CbGpPWpGaD
Aprepitant—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00464	CcSEcCtD
Aprepitant—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00464	CcSEcCtD
Aprepitant—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.00042	0.00451	CcSEcCtD
Aprepitant—Stomatitis—Colchicine—primary biliary cirrhosis	0.000418	0.00449	CcSEcCtD
Aprepitant—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00445	CcSEcCtD
Aprepitant—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00445	CcSEcCtD
Aprepitant—Haematuria—Colchicine—primary biliary cirrhosis	0.000409	0.00439	CcSEcCtD
Aprepitant—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00434	CcSEcCtD
Aprepitant—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00434	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000401	0.00431	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000401	0.00431	CcSEcCtD
Aprepitant—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00429	CcSEcCtD
Aprepitant—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00429	CcSEcCtD
Aprepitant—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00423	CcSEcCtD
Aprepitant—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00423	CcSEcCtD
Aprepitant—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00422	CcSEcCtD
Aprepitant—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00422	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000393	0.0165	CbGpPWpGaD
Aprepitant—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000391	0.0042	CcSEcCtD
Aprepitant—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000391	0.0042	CcSEcCtD
Aprepitant—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00416	CcSEcCtD
Aprepitant—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00416	CcSEcCtD
Aprepitant—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00414	CcSEcCtD
Aprepitant—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00414	CcSEcCtD
Aprepitant—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00414	CcSEcCtD
Aprepitant—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00414	CcSEcCtD
Aprepitant—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000383	0.00411	CcSEcCtD
Aprepitant—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00408	CcSEcCtD
Aprepitant—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00408	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—AQP4—primary biliary cirrhosis	0.000378	0.0159	CbGpPWpGaD
Aprepitant—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00407	CcSEcCtD
Aprepitant—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00407	CcSEcCtD
Aprepitant—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000377	0.00405	CcSEcCtD
Aprepitant—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000377	0.00405	CcSEcCtD
Aprepitant—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000377	0.0158	CbGpPWpGaD
Aprepitant—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00402	CcSEcCtD
Aprepitant—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00402	CcSEcCtD
Aprepitant—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00402	CcSEcCtD
Aprepitant—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00402	CcSEcCtD
Aprepitant—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000367	0.00394	CcSEcCtD
Aprepitant—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000367	0.00394	CcSEcCtD
Aprepitant—Eye disorder—Colchicine—primary biliary cirrhosis	0.000359	0.00386	CcSEcCtD
Aprepitant—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000347	0.00372	CcSEcCtD
Aprepitant—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00369	CcSEcCtD
Aprepitant—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00369	CcSEcCtD
Aprepitant—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00367	CcSEcCtD
Aprepitant—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00367	CcSEcCtD
Aprepitant—Alopecia—Colchicine—primary biliary cirrhosis	0.00034	0.00365	CcSEcCtD
Aprepitant—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00034	0.00365	CcSEcCtD
Aprepitant—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00034	0.00365	CcSEcCtD
Aprepitant—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00364	CcSEcCtD
Aprepitant—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00364	CcSEcCtD
Aprepitant—Malnutrition—Colchicine—primary biliary cirrhosis	0.000335	0.0036	CcSEcCtD
Aprepitant—TACR3—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000329	0.0138	CbGpPWpGaD
Aprepitant—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000323	0.00347	CcSEcCtD
Aprepitant—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000323	0.00347	CcSEcCtD
Aprepitant—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000322	0.00346	CcSEcCtD
Aprepitant—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000322	0.00346	CcSEcCtD
Aprepitant—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000322	0.00346	CcSEcCtD
Aprepitant—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000321	0.00345	CcSEcCtD
Aprepitant—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000321	0.00345	CcSEcCtD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000315	0.0132	CbGpPWpGaD
Aprepitant—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000314	0.00337	CcSEcCtD
Aprepitant—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000314	0.00337	CcSEcCtD
Aprepitant—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00335	CcSEcCtD
Aprepitant—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00335	CcSEcCtD
Aprepitant—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00335	CcSEcCtD
Aprepitant—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00335	CcSEcCtD
Aprepitant—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00031	0.00333	CcSEcCtD
Aprepitant—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00031	0.00333	CcSEcCtD
Aprepitant—Anaemia—Colchicine—primary biliary cirrhosis	0.000309	0.00332	CcSEcCtD
Aprepitant—Angioedema—Colchicine—primary biliary cirrhosis	0.000306	0.00329	CcSEcCtD
Aprepitant—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00328	CcSEcCtD
Aprepitant—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00328	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000305	0.0128	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.000303	0.0127	CbGpPWpGaD
Aprepitant—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00323	CcSEcCtD
Aprepitant—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00323	CcSEcCtD
Aprepitant—TACR3—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000299	0.0126	CbGpPWpGaD
Aprepitant—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000296	0.00318	CcSEcCtD
Aprepitant—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000296	0.00318	CcSEcCtD
Aprepitant—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00313	CcSEcCtD
Aprepitant—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00313	CcSEcCtD
Aprepitant—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00311	CcSEcCtD
Aprepitant—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00311	CcSEcCtD
Aprepitant—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000287	0.0121	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000286	0.012	CbGpPWpGaD
Aprepitant—Myalgia—Colchicine—primary biliary cirrhosis	0.000285	0.00306	CcSEcCtD
Aprepitant—Arthralgia—Colchicine—primary biliary cirrhosis	0.000285	0.00306	CcSEcCtD
Aprepitant—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000279	0.003	CcSEcCtD
Aprepitant—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000279	0.003	CcSEcCtD
Aprepitant—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00299	CcSEcCtD
Aprepitant—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00299	CcSEcCtD
Aprepitant—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00295	CcSEcCtD
Aprepitant—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00295	CcSEcCtD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000273	0.0115	CbGpPWpGaD
Aprepitant—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000271	0.00291	CcSEcCtD
Aprepitant—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000271	0.00291	CcSEcCtD
Aprepitant—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00027	0.0029	CcSEcCtD
Aprepitant—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00027	0.0029	CcSEcCtD
Aprepitant—Shock—Colchicine—primary biliary cirrhosis	0.000269	0.00289	CcSEcCtD
Aprepitant—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000268	0.00288	CcSEcCtD
Aprepitant—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000268	0.00287	CcSEcCtD
Aprepitant—CYP3A5—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000267	0.0112	CbGpPWpGaD
Aprepitant—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00286	CcSEcCtD
Aprepitant—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00286	CcSEcCtD
Aprepitant—Skin disorder—Colchicine—primary biliary cirrhosis	0.000265	0.00285	CcSEcCtD
Aprepitant—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000264	0.00284	CcSEcCtD
Aprepitant—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000264	0.00284	CcSEcCtD
Aprepitant—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000263	0.00282	CcSEcCtD
Aprepitant—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000263	0.00282	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000262	0.011	CbGpPWpGaD
Aprepitant—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000261	0.0028	CcSEcCtD
Aprepitant—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000261	0.0028	CcSEcCtD
Aprepitant—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00279	CcSEcCtD
Aprepitant—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00279	CcSEcCtD
Aprepitant—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00275	CcSEcCtD
Aprepitant—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00275	CcSEcCtD
Aprepitant—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00275	CcSEcCtD
Aprepitant—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00275	CcSEcCtD
Aprepitant—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00275	CcSEcCtD
Aprepitant—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00275	CcSEcCtD
Aprepitant—Hypotension—Colchicine—primary biliary cirrhosis	0.000255	0.00274	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000254	0.00273	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000254	0.00273	CcSEcCtD
Aprepitant—CYP3A5—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000253	0.0106	CbGpPWpGaD
Aprepitant—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000253	0.00272	CcSEcCtD
Aprepitant—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000253	0.00272	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000252	0.0106	CbGpPWpGaD
Aprepitant—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00269	CcSEcCtD
Aprepitant—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00269	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000249	0.00267	CcSEcCtD
Aprepitant—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00266	CcSEcCtD
Aprepitant—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00266	CcSEcCtD
Aprepitant—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000246	0.00264	CcSEcCtD
Aprepitant—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000246	0.00264	CcSEcCtD
Aprepitant—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000244	0.00262	CcSEcCtD
Aprepitant—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000244	0.00262	CcSEcCtD
Aprepitant—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000242	0.0026	CcSEcCtD
Aprepitant—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000242	0.0026	CcSEcCtD
Aprepitant—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000241	0.0101	CbGpPWpGaD
Aprepitant—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00259	CcSEcCtD
Aprepitant—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00259	CcSEcCtD
Aprepitant—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00258	CcSEcCtD
Aprepitant—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00258	CcSEcCtD
Aprepitant—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00257	CcSEcCtD
Aprepitant—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00257	CcSEcCtD
Aprepitant—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00256	CcSEcCtD
Aprepitant—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00256	CcSEcCtD
Aprepitant—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000238	0.00255	CcSEcCtD
Aprepitant—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00255	CcSEcCtD
Aprepitant—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00255	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000236	0.00253	CcSEcCtD
Aprepitant—Fatigue—Colchicine—primary biliary cirrhosis	0.000236	0.00253	CcSEcCtD
Aprepitant—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00251	CcSEcCtD
Aprepitant—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00251	CcSEcCtD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000234	0.00981	CbGpPWpGaD
Aprepitant—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00246	CcSEcCtD
Aprepitant—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00246	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000224	0.0024	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000224	0.0024	CcSEcCtD
Aprepitant—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000223	0.0024	CcSEcCtD
Aprepitant—TACR3—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000222	0.00933	CbGpPWpGaD
Aprepitant—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000222	0.00239	CcSEcCtD
Aprepitant—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000222	0.00239	CcSEcCtD
Aprepitant—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00237	CcSEcCtD
Aprepitant—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00237	CcSEcCtD
Aprepitant—TACR3—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.00022	0.00922	CbGpPWpGaD
Aprepitant—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000219	0.00235	CcSEcCtD
Aprepitant—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000219	0.00235	CcSEcCtD
Aprepitant—CYP1A2—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000219	0.00919	CbGpPWpGaD
Aprepitant—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00235	CcSEcCtD
Aprepitant—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00235	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—CXCL10—primary biliary cirrhosis	0.000218	0.00915	CbGpPWpGaD
Aprepitant—Urticaria—Colchicine—primary biliary cirrhosis	0.000217	0.00233	CcSEcCtD
Aprepitant—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000216	0.00232	CcSEcCtD
Aprepitant—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000216	0.00232	CcSEcCtD
Aprepitant—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000216	0.00232	CcSEcCtD
Aprepitant—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000213	0.00229	CcSEcCtD
Aprepitant—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000213	0.00229	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00228	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00228	CcSEcCtD
Aprepitant—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00227	CcSEcCtD
Aprepitant—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00227	CcSEcCtD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000211	0.00886	CbGpPWpGaD
Aprepitant—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00226	CcSEcCtD
Aprepitant—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00226	CcSEcCtD
Aprepitant—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00226	CcSEcCtD
Aprepitant—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00226	CcSEcCtD
Aprepitant—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000207	0.00868	CbGpPWpGaD
Aprepitant—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000206	0.00866	CbGpPWpGaD
Aprepitant—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000205	0.0086	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000205	0.00859	CbGpPWpGaD
Aprepitant—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000202	0.00217	CcSEcCtD
Aprepitant—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000202	0.00217	CcSEcCtD
Aprepitant—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000201	0.00216	CcSEcCtD
Aprepitant—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00216	CcSEcCtD
Aprepitant—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00216	CcSEcCtD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000199	0.00835	CbGpPWpGaD
Aprepitant—Asthenia—Colchicine—primary biliary cirrhosis	0.000196	0.00211	CcSEcCtD
Aprepitant—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000195	0.0021	CcSEcCtD
Aprepitant—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000195	0.0021	CcSEcCtD
Aprepitant—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000194	0.00209	CcSEcCtD
Aprepitant—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000194	0.00209	CcSEcCtD
Aprepitant—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000194	0.00209	CcSEcCtD
Aprepitant—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000194	0.00209	CcSEcCtD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000192	0.00805	CbGpPWpGaD
Aprepitant—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000189	0.00791	CbGpPWpGaD
Aprepitant—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000187	0.00201	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000186	0.00781	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL4—primary biliary cirrhosis	0.000182	0.00763	CbGpPWpGaD
Aprepitant—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00194	CcSEcCtD
Aprepitant—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00194	CcSEcCtD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00018	0.00757	CbGpPWpGaD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00018	0.00754	CbGpPWpGaD
Aprepitant—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000176	0.00189	CcSEcCtD
Aprepitant—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000176	0.00189	CcSEcCtD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000176	0.00739	CbGpPWpGaD
Aprepitant—Vomiting—Colchicine—primary biliary cirrhosis	0.000174	0.00187	CcSEcCtD
Aprepitant—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000174	0.00187	CcSEcCtD
Aprepitant—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000174	0.00187	CcSEcCtD
Aprepitant—Rash—Colchicine—primary biliary cirrhosis	0.000172	0.00185	CcSEcCtD
Aprepitant—Dermatitis—Colchicine—primary biliary cirrhosis	0.000172	0.00185	CcSEcCtD
Aprepitant—Headache—Colchicine—primary biliary cirrhosis	0.000171	0.00184	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000169	0.00709	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000169	0.00709	CbGpPWpGaD
Aprepitant—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000169	0.00709	CbGpPWpGaD
Aprepitant—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000168	0.0018	CcSEcCtD
Aprepitant—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000168	0.0018	CcSEcCtD
Aprepitant—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000162	0.00174	CcSEcCtD
Aprepitant—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000162	0.00174	CcSEcCtD
Aprepitant—Nausea—Colchicine—primary biliary cirrhosis	0.000162	0.00174	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000161	0.00677	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000161	0.00675	CbGpPWpGaD
Aprepitant—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000156	0.00168	CcSEcCtD
Aprepitant—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000156	0.00168	CcSEcCtD
Aprepitant—TACR3—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000156	0.00654	CbGpPWpGaD
Aprepitant—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00166	CcSEcCtD
Aprepitant—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00166	CcSEcCtD
Aprepitant—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00166	CcSEcCtD
Aprepitant—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00166	CcSEcCtD
Aprepitant—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000154	0.00165	CcSEcCtD
Aprepitant—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000154	0.00165	CcSEcCtD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000153	0.00644	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000153	0.00644	CbGpPWpGaD
Aprepitant—CYP1A2—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000153	0.0064	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000149	0.00625	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000149	0.00624	CbGpPWpGaD
Aprepitant—CYP3A5—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000149	0.00624	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000147	0.00618	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000146	0.00613	CbGpPWpGaD
Aprepitant—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000146	0.00157	CcSEcCtD
Aprepitant—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000146	0.00157	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—NOS2—primary biliary cirrhosis	0.000143	0.00602	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.000135	0.00568	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000134	0.00563	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000128	0.00538	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000126	0.00529	CbGpPWpGaD
Aprepitant—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000124	0.00522	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000123	0.00516	CbGpPWpGaD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000118	0.00497	CbGpPWpGaD
Aprepitant—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000118	0.00494	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.000115	0.00483	CbGpPWpGaD
Aprepitant—CYP2C19—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000115	0.00482	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000112	0.00471	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000109	0.00456	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000107	0.0045	CbGpPWpGaD
Aprepitant—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000105	0.0044	CbGpPWpGaD
Aprepitant—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000105	0.0044	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000104	0.00435	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	9.99e-05	0.00419	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCR5—primary biliary cirrhosis	9.98e-05	0.00419	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	9.71e-05	0.00408	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—MMP9—primary biliary cirrhosis	9.24e-05	0.00388	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	9.09e-05	0.00381	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCL9—primary biliary cirrhosis	9.07e-05	0.00381	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	9.03e-05	0.00379	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	8.8e-05	0.00369	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	8.6e-05	0.00361	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	8.49e-05	0.00356	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ELMO1—primary biliary cirrhosis	8.39e-05	0.00352	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	8.25e-05	0.00346	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	8.25e-05	0.00346	CbGpPWpGaD
Aprepitant—CYP2C9—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	8.23e-05	0.00346	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CXCL10—primary biliary cirrhosis	7.99e-05	0.00336	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	7.61e-05	0.00319	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CCL5—primary biliary cirrhosis	7.58e-05	0.00318	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	7.49e-05	0.00315	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	7.32e-05	0.00307	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—MMP3—primary biliary cirrhosis	7.29e-05	0.00306	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	7.26e-05	0.00305	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	7.19e-05	0.00302	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	7.04e-05	0.00295	CbGpPWpGaD
Aprepitant—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	6.91e-05	0.0029	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL5—primary biliary cirrhosis	6.88e-05	0.00289	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL5—primary biliary cirrhosis	6.55e-05	0.00275	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—AGT—primary biliary cirrhosis	6.34e-05	0.00266	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—GGT1—primary biliary cirrhosis	6.01e-05	0.00252	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—AGT—primary biliary cirrhosis	5.76e-05	0.00242	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	5.64e-05	0.00237	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—AGT—primary biliary cirrhosis	5.48e-05	0.0023	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	5.19e-05	0.00218	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDH5—primary biliary cirrhosis	5.06e-05	0.00213	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCR5—primary biliary cirrhosis	4.88e-05	0.00205	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	4.74e-05	0.00199	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.72e-05	0.00198	CbGpPWpGaD
Aprepitant—CYP1A2—Phase II conjugation—GGT1—primary biliary cirrhosis	4.48e-05	0.00188	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL9—primary biliary cirrhosis	4.43e-05	0.00186	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	4.39e-05	0.00184	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—GGT1—primary biliary cirrhosis	4.35e-05	0.00182	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP3—primary biliary cirrhosis	4.31e-05	0.00181	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TYK2—primary biliary cirrhosis	4.3e-05	0.00181	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	4.3e-05	0.0018	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—LBR—primary biliary cirrhosis	4.14e-05	0.00174	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ELMO1—primary biliary cirrhosis	4.1e-05	0.00172	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL5—primary biliary cirrhosis	4.06e-05	0.00171	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	4.05e-05	0.0017	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.94e-05	0.00165	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	3.9e-05	0.00164	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	3.7e-05	0.00155	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MMP3—primary biliary cirrhosis	3.56e-05	0.00149	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.41e-05	0.00143	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AGT—primary biliary cirrhosis	3.4e-05	0.00143	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—GGT1—primary biliary cirrhosis	3.36e-05	0.00141	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL5—primary biliary cirrhosis	3.36e-05	0.00141	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	3.15e-05	0.00132	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AGT—primary biliary cirrhosis	3.1e-05	0.0013	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	3.06e-05	0.00129	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	3.04e-05	0.00128	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CD80—primary biliary cirrhosis	3.01e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—OGDH—primary biliary cirrhosis	2.99e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LBR—primary biliary cirrhosis	2.99e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	2.87e-05	0.0012	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AGT—primary biliary cirrhosis	2.81e-05	0.00118	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PDHX—primary biliary cirrhosis	2.67e-05	0.00112	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	2.62e-05	0.0011	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TYK2—primary biliary cirrhosis	2.54e-05	0.00107	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—DLAT—primary biliary cirrhosis	2.51e-05	0.00105	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCB4—primary biliary cirrhosis	2.51e-05	0.00105	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	2.45e-05	0.00103	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LBR—primary biliary cirrhosis	2.31e-05	0.000971	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.31e-05	0.000968	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—OGDH—primary biliary cirrhosis	2.16e-05	0.000908	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	2.11e-05	0.000885	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP3—primary biliary cirrhosis	2.1e-05	0.000883	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TYK2—primary biliary cirrhosis	2.1e-05	0.000882	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	2.02e-05	0.000848	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP9—primary biliary cirrhosis	2e-05	0.000841	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL5—primary biliary cirrhosis	1.99e-05	0.000833	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.98e-05	0.000832	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PDHX—primary biliary cirrhosis	1.93e-05	0.000809	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.92e-05	0.000807	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCB4—primary biliary cirrhosis	1.81e-05	0.000761	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—DLAT—primary biliary cirrhosis	1.81e-05	0.000761	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	1.8e-05	0.000757	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	1.67e-05	0.000702	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.67e-05	0.0007	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AGT—primary biliary cirrhosis	1.66e-05	0.000697	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	1.53e-05	0.00064	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.51e-05	0.000633	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NUP210—primary biliary cirrhosis	1.51e-05	0.000633	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	1.49e-05	0.000626	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CD80—primary biliary cirrhosis	1.47e-05	0.000617	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	1.4e-05	0.000588	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	1.4e-05	0.000588	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCG2—primary biliary cirrhosis	1.4e-05	0.000588	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.39e-05	0.000584	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.38e-05	0.000577	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	1.36e-05	0.000571	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	1.3e-05	0.000547	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.29e-05	0.000542	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	1.28e-05	0.000536	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	1.28e-05	0.000536	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.24e-05	0.000521	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CTGF—primary biliary cirrhosis	1.2e-05	0.000505	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GOT2—primary biliary cirrhosis	1.19e-05	0.0005	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.18e-05	0.000494	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.18e-05	0.000493	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	1.16e-05	0.000488	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.15e-05	0.000482	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.09e-05	0.000458	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	1.09e-05	0.000458	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	1.09e-05	0.000457	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.05e-05	0.00044	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GGT1—primary biliary cirrhosis	1.03e-05	0.000432	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GOT1—primary biliary cirrhosis	1.03e-05	0.000432	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	1.01e-05	0.000425	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.01e-05	0.000422	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.01e-05	0.000422	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—primary biliary cirrhosis	9.78e-06	0.00041	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	9.68e-06	0.000406	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARGC1A—primary biliary cirrhosis	9.15e-06	0.000384	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	8.96e-06	0.000376	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	8.95e-06	0.000376	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	8.95e-06	0.000376	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	8.69e-06	0.000365	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	8.61e-06	0.000362	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	8.43e-06	0.000354	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	8.43e-06	0.000354	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	8.42e-06	0.000354	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	8.16e-06	0.000342	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	7.83e-06	0.000329	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	7.68e-06	0.000322	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	7.43e-06	0.000312	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	7.43e-06	0.000312	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	7.14e-06	0.0003	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AGT—primary biliary cirrhosis	7.13e-06	0.000299	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	6.97e-06	0.000293	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.87e-06	0.000288	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	6.72e-06	0.000282	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	6.66e-06	0.000279	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	6.62e-06	0.000278	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	6.56e-06	0.000275	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.26e-06	0.000263	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	6.13e-06	0.000257	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	6.1e-06	0.000256	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	6.07e-06	0.000255	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	5.75e-06	0.000241	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	5.75e-06	0.000241	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—primary biliary cirrhosis	5.47e-06	0.00023	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.35e-06	0.000225	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	5.24e-06	0.00022	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	5.24e-06	0.00022	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	5.24e-06	0.00022	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	5.19e-06	0.000218	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	5.15e-06	0.000216	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	5.12e-06	0.000215	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	5.07e-06	0.000213	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	4.71e-06	0.000198	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	4.66e-06	0.000196	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	4.48e-06	0.000188	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	4.48e-06	0.000188	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	4.04e-06	0.00017	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	4e-06	0.000168	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	3.99e-06	0.000167	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	3.98e-06	0.000167	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	3.95e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	3.63e-06	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	3.46e-06	0.000145	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	3.46e-06	0.000145	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	3.1e-06	0.00013	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	3.08e-06	0.000129	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	3.06e-06	0.000128	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	2.79e-06	0.000117	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	2.4e-06	0.000101	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	2.38e-06	0.0001	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.84e-06	7.72e-05	CbGpPWpGaD
